Center-Authored Papers

Filters: Author is Carter, H Ballentine  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
2010
Kawachi MH, Bahnson RR, Barry M, Busby EJ, Carroll PR, Carter BH, Catalona WJ, Cookson MS, Epstein JI, Etzioni R et al..  2010.  NCCN clinical practice guidelines in oncology: prostate cancer early detection.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(2):240-62.
2013
Carter BH, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH et al..  2013.  Early Detection of Prostate Cancer: AUA Guideline.. The Journal of urology. Abstract
2014
Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter BH, Klotz L et al..  2014.  The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Soci. Archives of pathology & laboratory medicine. Abstract
Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter BH, Carroll P, Etzioni R.  2014.  Overdiagnosis and Overtreatment of Prostate Cancer.. European urology. Abstract
258
Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter BH, Klotz L et al..  2014.  The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Soci. Archives of pathology & laboratory medicine. Abstract
Aged
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
August 2014
Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter BH, Klotz L et al..  2014.  The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Soci. Archives of pathology & laboratory medicine. Abstract
Center-Authored Paper
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
Kawachi MH, Bahnson RR, Barry M, Busby EJ, Carroll PR, Carter BH, Catalona WJ, Cookson MS, Epstein JI, Etzioni R et al..  2010.  NCCN clinical practice guidelines in oncology: prostate cancer early detection.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(2):240-62.
Early Detection of Cancer
Kawachi MH, Bahnson RR, Barry M, Busby EJ, Carroll PR, Carter BH, Catalona WJ, Cookson MS, Epstein JI, Etzioni R et al..  2010.  NCCN clinical practice guidelines in oncology: prostate cancer early detection.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(2):240-62.
February 2014
Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter BH, Carroll P, Etzioni R.  2014.  Overdiagnosis and Overtreatment of Prostate Cancer.. European urology. Abstract
Guideline Adherence
Kawachi MH, Bahnson RR, Barry M, Busby EJ, Carroll PR, Carter BH, Catalona WJ, Cookson MS, Epstein JI, Etzioni R et al..  2010.  NCCN clinical practice guidelines in oncology: prostate cancer early detection.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(2):240-62.
Humans
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
Kawachi MH, Bahnson RR, Barry M, Busby EJ, Carroll PR, Carter BH, Catalona WJ, Cookson MS, Epstein JI, Etzioni R et al..  2010.  NCCN clinical practice guidelines in oncology: prostate cancer early detection.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(2):240-62.
Insulin-Like Growth Factor Binding Protein 2
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
Insulin-Like Growth Factor Binding Protein 3
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
Insulin-Like Growth Factor Binding Proteins
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
Insulin-Like Growth Factor I
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
Insulin-Like Growth Factor II
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
Male
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract
Kawachi MH, Bahnson RR, Barry M, Busby EJ, Carroll PR, Carter BH, Catalona WJ, Cookson MS, Epstein JI, Etzioni R et al..  2010.  NCCN clinical practice guidelines in oncology: prostate cancer early detection.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(2):240-62.
May 2013
Carter BH, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH et al..  2013.  Early Detection of Prostate Cancer: AUA Guideline.. The Journal of urology. Abstract
Medical Oncology
Kawachi MH, Bahnson RR, Barry M, Busby EJ, Carroll PR, Carter BH, Catalona WJ, Cookson MS, Epstein JI, Etzioni R et al..  2010.  NCCN clinical practice guidelines in oncology: prostate cancer early detection.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(2):240-62.
Middle Aged
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter BH, Metter JE, Chen C, Weiss NS, Fitzpatrick A et al..  2008.  Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.. Annals of internal medicine. 149(7):461-71,W83-8. Abstract